Expert analysis of the policy shifts, market dynamics, and strategic imperatives shaping pharmaceutical pricing in 2026 and beyond
Explore our comprehensive guide to understanding the pharmaceutical pricing landscape in 2026
💡 Tip: Click the fullscreen icon in the top-right corner for the best reading experience
This eBook provides pharmaceutical pricing leaders with the intelligence and strategic frameworks needed to navigate 2026's policy landscape
Expert breakdown of MFN, IRA, and global pricing policy developments affecting pharmaceutical market access in 2026
Actionable frameworks for pricing teams to prepare for policy shifts and market dynamics in the year ahead
Real-world examples of how pharmaceutical companies are using GPI's intelligence and platforms to navigate complexity
Expert forecasts from GPI's consulting team on the key trends and challenges pharmaceutical pricing teams will face
Concrete steps pricing teams can take now to position their organisations for success in the evolving landscape
Intelligence from GPI's proprietary pharmaceutical pricing data covering 30+ markets and 1,000+ products
Connect with our pharmaceutical pricing experts to understand how GPI's proprietary data, analytics platforms, and specialist pricing expertise can support your organisation's success.